NVO Exhibits High Monthly Volume Amid Downtrend – Potential Accumulation Phase
📉 Post:
Novo Nordisk (NVO) has experienced a significant decline from its 52-week high of $148.15 to a recent low of $57.00. However, the monthly chart reveals an unusually high trading volume, which may indicate accumulation by institutional investors.
Key Observations:
High monthly trading volume, suggesting potential accumulation.
Current price: $71.50.
52-week range: $57.00 – $148.15.
Trading below the 209-day EMA, indicating a bearish long-term trend.
While the increased volume could signify a shift in sentiment, it's essential to wait for confirmation through a break above key resistance levels before considering a bullish position.
Not financial advice – just sharing my technical perspective.
#NVO #NovoNordisk #StockAnalysis #TechnicalAnalysis #EMA200 #VolumeAnalysis #PotentialReversal
📉 Post:
Novo Nordisk (NVO) has experienced a significant decline from its 52-week high of $148.15 to a recent low of $57.00. However, the monthly chart reveals an unusually high trading volume, which may indicate accumulation by institutional investors.
Key Observations:
High monthly trading volume, suggesting potential accumulation.
Current price: $71.50.
52-week range: $57.00 – $148.15.
Trading below the 209-day EMA, indicating a bearish long-term trend.
While the increased volume could signify a shift in sentiment, it's essential to wait for confirmation through a break above key resistance levels before considering a bullish position.
Not financial advice – just sharing my technical perspective.
#NVO #NovoNordisk #StockAnalysis #TechnicalAnalysis #EMA200 #VolumeAnalysis #PotentialReversal
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.